A simple blood test or a quick tablet game can reveal Alzheimer’s-related brain changes years before memory problems start, and that rewrites what prevention can look like. We walk through the new detection tools, what early treatments and trials are trying to do, and why ethics and access may decide whether this revolution helps everyone.
• the shift from late diagnosis to risk reduction and early treatment
• why symptom-based diagnosis misses the best intervention window
• how digital cognitive tests detect microhesitations and processing delays
• how blood biomarkers reveal brain pathology without PET scans or lumbar punctures
• why early detection matters only if action follows
• approved medicines that slow early stages and what trials test pre-symptom
• the heart disease prevention analogy for brain health
• the U.S. POINTER trial pillars: physical activity, nutrition, social and cognitive challenge, health coaching
• why structure and accountability turn habits into clinical intervention
• counseling challenges and the psychological burden of a pre-diagnosis
• screening guidelines, insurance coverage, and equitable access as the next bottleneck
Keep asking the big questions, keep challenging the old models, and most importantly, keep learning.
This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice.
Never miss an episode—subscribe on your favorite podcast app!
